Science Explorer Back to mapMap
Discussion
Company · Hanover · Germany

Pharis Biotec (Germany)

pharis.deROR OpenAlex
Research works
10
▼ 18% vs 2018-21
Citations
127
12.7 per fractional work
Top-10% rate
5.1%
all institutions 10.0%
Open access
47%
world 40%
International
59%
world 18%
Pharis Biotec (Germany)

Not ranked overall: Pharis Biotec (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pharis Biotec (Germany) work in?

In all years, 46% of research at Pharis Biotec (Germany) is in Health Sciences, 45% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (11%). It does 1.7× the world's share of Life Sciences.

Health Sciences: 5 fractional works · 46.1% of its workMedicine: 5 fractional works · 45.3% of its workOncology: 2 fractional works · 18.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 3.9% of its workEpidemiology: 0 fractional works · 3.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 3.4% of its workHematology: 0 fractional works · 2.6% of its workPhysiology: 0 fractional works · 2.3% of its workPathology and Forensic Medicine: 0 fractional works · 2.1% of its workNeurology: 0 fractional works · 1.9% of its workGenetics: 0 fractional works · 1.5% of its workDermatology: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.6% of its workObstetrics and Gynecology: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 4 fractional works · 44.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 32.7% of its workMolecular Biology: 2 fractional works · 16.7% of its workBiotechnology: 1 fractional works · 8.6% of its workGenetics: 0 fractional works · 4.2% of its workCell Biology: 0 fractional works · 1.9% of its workMolecular Medicine: 0 fractional works · 0.8% of its workCancer Research: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 10.9% of its workImmunology: 1 fractional works · 7.3% of its workVirology: 0 fractional works · 2.0% of its workMicrobiology: 0 fractional works · 1.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workToxicology: 0 fractional works · 0.8% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workFood Science: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 5.9% of its workEngineering: 0 fractional works · 3.3% of its workBuilding and Construction: 0 fractional works · 1.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.7% of its workChemistry: 0 fractional works · 1.1% of its workOrganic Chemistry: 0 fractional works · 1.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.8% of its workPaleontology: 0 fractional works · 0.8% of its workComputer Science: 0 fractional works · 0.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 3.4% of its workPsychology: 0 fractional works · 1.7% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.7% of its workSocial Sciences: 0 fractional works · 1.7% of its workTransportation: 0 fractional works · 1.7% of its workALL ITS WORKPharis Biotec(Germany)10fractional works, all years
Life Sciences45%Physical Sciences6%Health Sciences46%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine545.3%
    2. Nursing00.7%
    3. Health Professions00.1%
    1. Biochemistry, Genetics and Molecular Biology332.7%
    2. Immunology and Microbiology110.9%
    3. Pharmacology, Toxicology and Pharmaceutics00.8%
    4. Agricultural and Biological Sciences00.3%
    1. Engineering03.3%
    2. Chemistry01.1%
    3. Earth and Planetary Sciences00.8%
    4. Computer Science00.5%
    5. Environmental Science00.2%
    1. Psychology01.7%
    2. Social Sciences01.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Pharis Biotec (Germany)?

The most cited paper from Pharis Biotec (Germany) is "Discovery and Characterization of an Endogenous CXCR4 Antagonist" (Onofrio Zirafi et al., 2015), with 104 citations. Next come "A natural point mutation changes both target selectivity and mechanism of action of sea anemone toxins" (89) and "Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide" (85).

Most cited papers
#PaperReleasedCitations
1 Discovery and Characterization of an Endogenous CXCR4 Antagonist Onofrio Zirafi et al. · Cell Reports Open access 25 Apr 2015 104
2 A natural point mutation changes both target selectivity and mechanism of action of sea anemone toxins Steve Peigneur, László Béress, Carolina Möller et al. · The FASEB Journal 12 Sep 2012 89
3 Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide Wolf‐Georg Forssmann, Yu-Han The, Matthias Stoll et al. · Science Translational Medicine 22 Dec 2010 85
4 Immunotherapy of patients with hormone‐refractory prostate carcinoma pre‐treated with interferon‐gamma and vaccinated with autologous PSA‐peptide loaded dendritic cells—A pilot study Bernd Hildenbrand, Brian C. Sauer, O. Kalis et al. · The Prostate 29 Jan 2007 56
5 Challenging the “gold standard” of colony-forming units - Validation of a multiplex real-time PCR for quantification of viable Campylobacter spp. in meat rinses Kerstin Stingl et al. · International Journal of Food Microbiology Open access 24 Sep 2021 36
All 25 most cited papers, with filters and sorting

Which research topics does Pharis Biotec (Germany) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Cardiovascular Function and Risk Factors, Alzheimer's disease research and treatments and Antibiotic Resistance in Bacteria.

CAR-T cell therapy research: 0 fractional worksCardiovascular Function and Risk Factors: 0 fractional worksAlzheimer's disease rese…0Alzheimer's disease research and treatments: 0 fractional worksAntibiotic Resistance in Bacteria: 0 fractional worksAmyloidosis: Diagnosis, Treatment, Outcomes: 0 fractional worksSarcoma Diagnosis and Treatment: 0 fractional worksVirus-based gene therapy research: 0 fractional worksCardiovascular, Neuropep…0Cardiovascular, Neuropeptides, and Oxidative Stress Research: 0 fractional worksSkin and Cellular Biology Research: 0 fractional worksCardiovascular Disease and Adiposity: 0 fractional works
OncologyCardiology and Cardiovascular MedicinePhysiologyMolecular Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
  3. 3 Alzheimer's disease research and treatments Physiology 0 works
  4. 4 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  5. 5 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 0 works
  6. 6 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  7. 7 Virus-based gene therapy research Genetics 0 works
  8. 8 Cardiovascular, Neuropeptides, and Oxidative Stress Research Surgery 0 works
  9. 9 Skin and Cellular Biology Research Cell Biology 0 works
  10. 10 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.6%not open53.4%

World: 40% of research is openly available.

with international co-authors59.0%domestic only41.0%

World: 18% is written across borders.

How has Pharis Biotec (Germany)'s research output changed?

Output in 2022-2025 was 18% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pharis Biotec (Germany) as a percentage of every work published that year, 0.000024% in 2024.

still counting0.000025%0.000050%0.000075%Pharis Biotec (Germany)0.0000041% in 202520102020

Fractional works of Pharis Biotec (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hanover

All research institutions in Hanover

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pharis Biotec (Germany). Posts are plain text and can be reported.